Constance Höfer

Constance Höfer is an experienced executive in the pharmaceutical and biopharmaceutical industry, currently serving as Executive Director and Global Program Head for Neurology & Immunology at Merck Group since May 2022. Prior roles include Global Program Head at Sandoz Biopharmaceuticals and Partner at Vitilis, where Constance provided independent reviews of project strategies and regulatory interactions. Additional experience encompasses leadership positions such as COO and CDO at Priaxon AG, and Vice President of Drug Development at MediGene AG, where Constance oversaw non-clinical R&D activities. Earlier in the career, Constance held positions at Merck KGaA, Solvay Pharmaceuticals, and Celltech plc, contributing expertise in DMPK studies and drug development. Educational qualifications include a PhD in Pharmacokinetics and Genetics from Newcastle University and a BSc (Hons) in Genetics & Cell Biology from The University of Manchester.